Evidence map›Paper›PMID 25866088›Full record

ReviewAging cell2015

Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake.

Adam P Sharples, David C Hughes, Colleen S Deane, Amarjit Saini, Colin Selman, Claire E Stewart

Abstract readReview
In one paragraph

Review in Aging cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Nutrients · 2024
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Biomolecular Basis of Life.Metabolites · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam P SharplesStem Cells, Ageing & Molecular Physiology Unit, Research Institute for Sport and Exercise Sciences (RISES), Exercise Metabolism and Adaptation Research Group (EMARG), Liverpool John Moores University, Tom Reilly Building, Liverpool, L3 3AF, UK.
David C HughesStem Cells, Ageing & Molecular Physiology Unit, Research Institute for Sport and Exercise Sciences (RISES), Exercise Metabolism and Adaptation Research Group (EMARG), Liverpool John Moores University, Tom Reilly Building, Liverpool, L3 3AF, UK.
Colleen S DeaneMRC/ARUK Centre of Excellence for Musculoskeletal Ageing Research, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, DE22 3DT, UK.
Amarjit SainiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden.
Colin SelmanGlasgow Ageing Research Network (GARNER), Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Claire E StewartStem Cells, Ageing & Molecular Physiology Unit, Research Institute for Sport and Exercise Sciences (RISES), Exercise Metabolism and Adaptation Research Group (EMARG), Liverpool John Moores University, Tom Reilly Building, Liverpool, L3 3AF, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advancing age is associated with a progressive loss of skeletal muscle (SkM) mass and function. Given the worldwide aging demographics, this is a major contributor to morbidity, escalating socio-economic costs and ultimately mortality. Previously, it has been established that a decrease in regenerative capacity in addition to SkM loss with age coincides with suppression of insulin/insulin-like growth factor signalling pathways. However, genetic or pharmacological modulations of these highly conserved pathways have been observed to significantly enhance life and healthspan in various species, including mammals. This therefore provides a controversial paradigm in which reduced regenerative capacity of skeletal muscle tissue with age potentially promotes longevity of the organism. This paradox will be assessed and considered in the light of the following: (i) the genetic knockout, overexpression and pharmacological models that induce lifespan extension (e.g. IRS-1/s6K KO, mTOR inhibition) versus the important role of these signalling pathways in SkM growth and adaptation; (ii) the role of the sirtuins (SIRTs) in longevity versus their emerging role in SkM regeneration and survival under catabolic stress; (iii) the role of dietary restriction and its impact on longevity versus skeletal muscle mass regulation; (iv) the crosstalk between cellular energy metabolism (AMPK/TSC2/SIRT1) and survival (FOXO) versus growth and repair of SkM (e.g. AMPK vs. mTOR); and (v) the impact of protein feeding in combination with dietary restriction will be discussed as a potential intervention to maintain SkM mass while increasing longevity and enabling healthy aging.

Indexed as

Caloric RestrictionAgingAMP-Activated Protein KinasesAnimalsDietDietary ProteinsEnzyme ActivationGene Expression RegulationHumansInsulinInsulin-Like Growth Factor ILongevityMiceMuscle, SkeletalSignal TransductionSirtuinsAMP-Activated Protein KinasesDietary ProteinsInsulinInsulin-Like Growth Factor IMTOR protein, humanSirtuinsTOR Serine-Threonine KinasesAKTAMPKcachexiacalorie restrictionFOXOhigh-protein dietsIGF-IIRS-1lifespanlongevityMAFBxmTORMURFregenerationsarcopeniasatellite cellsSIRTSkMTSC

Identifiers

PMID25866088
PMCPMC4531066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.